Full Transcript Introduction and Ophthalmology Background 0:00 Doctors that Svetlana Trofimova. 0:02 Thank you so much for agreeing to this interview. 0:04 It is such an honor to have you here today. 0:07 Thank you for having me. 0:08 Thank you very much. That you invited me. Thank you very much. 0:11 Anthony. 0:12 Well, this is something this is a conversation 0:14 I've been looking forward to for a long time, so I'm so thrilled. 0:17 So before we jump right into our big topic, 0:20 I just wanted to talk a little bit about you. 0:22 Like you first trained 0:24 as a physician in ophthalmology and then in your academic work, 0:28 you went deep into diabetic retinopathy and retinitis 0:31 pigmentosa, which are some very serious eye conditions. 0:34 What did you see in those patients that really convinced you that 0:38 aging and regeneration, it's not about organ by organ, 0:42 but it's really about the whole body, about the whole system story. 0:45 Like, how did that connection come by for you? 0:49 Yes. To tell the truth, I was lucky 0:52 because I had a really good teacher. 0:56 I was taught that I is always 1:01 a part of our nervous and vascular system. 1:07 And of course, the eye is a complex organ. 1:12 Not to mention. 1:14 That retina., 1:17 Retina. 1:19 Is like a computer because retina 1:22 consists of ten layers. 1:25 And late Aretino lay 1:28 on the coral vessels. 1:31 Vessels, vessels. 1:33 The part of the retina. 1:35 Retina in okay. Vessels. Okay. 1:39 And that is why, of course, impossible to treat retina 1:45 without influence on the vessel system. 1:50 For example, small, small, small example 1:55 patients with diabetic retinopathy. 1:58 Of course. 1:59 First of all, the retina 2:03 is complication of this disease. 2:06 And that is why the problems in the vessels 2:10 and in possible to achieve 2:14 to positive clinical results 2:16 only you to read 2:19 the retina only comprehensive approach 2:23 to treat such patients can give a positive the clinical results. 2:29 It's absolutely I think every 2:32 every doctor knows about this one. 2:35 Yeah. No, that makes sense. 2:37 You know, have you heard? 2:38 Are you're familiar obviously 2:40 with the GLP, the weight loss drugs that are all the rage right now. 2:44 Right. 2:44 The the Osiek and the moon, the semaglutide tours appetite and I don't. 2:49 Have you heard about a condition that can affect those patients 2:53 where they lose their vision overnight? 2:56 Do you. 2:57 Have you heard about this? 2:58 First of all, the patient visa a debit is maladies. 3:02 It is necessary to treat the diabetes. 3:06 Yeah that is why it is necessary to 3:10 support is a method of roses 3:13 and all of medicine 3:16 insulin all the medicine for sugar. 3:21 Is it necessary to using for such patients? 3:25 Absolutely. 3:26 And the complication as debit is written opposite 3:30 it is a second step for treatment. 3:33 Such patients. 3:35 And impossible to achieve the good visual acuity if the.
Systemic View of Eye Disease and Diabetes 3:40 Patient. 3:41 Have a problem with his metabolic process. 3:46 Right. Right. 3:47 Because of the effect on the systemic, on blood flow, blood supply 3:50 and all the different things. 3:52 Yeah. Absolutely. Right. 3:53 Yes. Yes. 3:54 And it depends. 3:56 Not only is it retinal pathology. 3:58 It depends for all of diseases in our organism. 4:03 Impossible to treat only I only heart only 4:10 leave. 4:11 We have to treat the all of organism. 4:15 And in our medical center, we. 4:20 First of all, we treat the patient, not the problem. 4:24 The question? 4:25 Yeah, of course, that's that's the hallmark of the 4:29 of the medicine that actually works. Right. 4:31 So let's jump into the bio regulators. 4:35 When you first encountered them. 4:37 What did they mean to you then versus like do you see them differently 4:42 now after you know how many years of research 4:45 and clinical work like when you first came across them, what was like? 4:49 What did you think about them then 4:50 and now after all this time of working with them clinically? 4:54 How do you what do you think about them now? 4:57 How do you feel about the bio regulators? 4:59 Where would you put them? 5:01 Oh it was I remember my first patience with reading this. 5:06 Pigmentosa. Yes. Yeah. Yeah. 5:09 It was a rather young man about 35 years old, but it was 30 years ago. 5:16 And. Okay. Yes. 5:18 And I was after university, and, 5:23 when I 5:24 came across these tides, I know that 5:28 the conventional medicine proposed only the observation. 5:34 They have nothing. 5:35 Yeah. Yeah. 5:36 And can it give any treatment? 5:39 And when my patient got the tides 5:43 and when I met with him and three months, I was. 5:48 It is really surprised because the visual acuity increased 5:54 and the field of vision as painted, which is an of first treatment 6:00 three months not the treatment last ten days, 6:04 but the next hour meeting was in three months. 6:09 And in three months we checked these patients 6:13 he visual acuity he the result of computer pyramid. 6:19 It is a special investigation for such patient. 6:23 And I got that really brilliant results. 6:28 He's not down but his visual acuity increased. 6:33 Crazy. Yeah, that is crazy. 6:36 For for a condition. 6:37 Yeah. 6:37 For a condition that is considered untreatable by conventional medicine. 6:41 Right. Yes. That's. 6:43 I don't like to tell about conventional medicine, 6:47 because now, maybe a little bit later 6:52 we will talk about this one with you. 6:55 But now in, in the pharmaceutical market 6:59 in Russia, there are at ten medicine. 7:03 We speak tied with having sun tied. 7:05 Really. Okay. 7:06 It is a conventional medicine in Russia. 7:10 Not in North America. 7:12 Russia, in Russia, but. 7:17 Do you know 7:18 that is a very difficult to carry out 7:22 the all of preclinical and clinical investigation. 7:26 And if we decide to, 7:31 if you decide to sell a 7:34 of these medicine and another country, it doesn't matter where in European 7:39 country in America we have to repeat 7:43 the same in the each countries. 7:46 These clinical and clinical investigation. 7:49 Right. 7:50 And that is why all of the patients from different countries come to us 7:55 to come to Saint Petersburg and receive these medicines, this treatment. 8:01 But of course, the food supplements now we produce in the Europe. 8:06 Yeah, yeah. 8:07 The natural bio regulators.
First Clinical Results With Bio Regulators 8:10 The natural synthetic. 8:11 And the synthetic. Yeah. 8:13 So, well, you worked very closely in a field shaped by Professor Vladimir. 8:19 What is something people outside that world. 8:22 What what did they misunderstand about his original scientific question? 8:26 Like, what's, you know, what was the original scientific question 8:30 that got professor moving in this direction to develop? 8:34 He developed this field like this is his. 8:37 Thank you very much for this question. 8:39 Thank you very much. 8:41 It is very it is really a very important question 8:44 because some of the people think that having sun, 8:50 he was looking for elixir of age. 8:55 No, no, no, no, of course no. 8:59 Because he if you don't mind, 9:04 I will tell you 9:07 about how these tides we are aware created. 9:10 Sure. Please. 9:13 I think everybody knows about the 9:16 about the theory of the stress. 9:20 The theory of stress? Yeah. Okay. 9:23 And this theory, 9:27 in 1954, the very popular scientist 9:33 Gans, Hans Cilium, proposed 9:36 that the high level of stress influence 9:40 on the our may or organs. 9:45 They are 9:47 timeless and pine gland and under the stress 9:53 the functional activity of these organ inhibitors. 9:58 And 40 years ago, young scientists 10:03 having son with his friend Morozov suggested 10:08 that there are 10:12 substance that regulates 10:15 the functional activity of these of these organs 10:19 and this substance have been found, 10:24 and this and it will 10:29 and it were because 10:33 under the effect of pineal gland peptide and timeless, 10:39 the functional activity of these organs 10:44 increased and 10:47 the slow and or 10:50 that is why is it possible to talk of the any age related diseases. 10:56 And 30 years investigation proved 11:01 this idea. 11:04 Yeah. And 11:06 of course the first big tides 11:10 were extract from different organs and tissues 11:13 and first organs were pioneering gland and timers. 11:18 Yeah. 11:18 And thus medicine with ties 11:22 in the pharmaceutical 11:25 markets in the Russia where 11:28 Tamerlane and epithelial means 11:32 that regulate functional activity of those then 11:36 using mass spectrometry, the amino acids 11:42 sequence in the extract was formed. 11:47 Okay. Yeah. 11:49 And small example. 11:53 For example, if we take a timeline at Extract 11:57 and Zara and many 12:01 synthetic tides at this extract time 12:06 a gene will loan Christians. 12:10 There are many, many guys in the extract. 12:14 Yeah. 12:15 And that is why the complex the extracts 12:21 have a more 12:23 wide efficacy than as a short 12:27 but short riptides. 12:30 These scientific cryptids, 12:32 we know cancer regulated gene activity. 12:35 That is why these people died. 12:38 Have a 12:41 special activity according to the disease. 12:46 So you're talking now epitaph on the long Simonton. 12:51 Yeah. Yeah. 12:53 There are many short bits. 12:55 You're absolutely right. 12:56 Time my gene villain epithelial crease again. 13:02 Pineal on is a very important short 13:06 bicycle support of cognitive function. 13:09 And despite shows as a good positive
Origins of the Peptide Research Program 13:13 clinical results in patients with Alzheimer's disease. 13:17 And so when when you're. 13:19 I'm going to go a little off script here for a minute. 13:22 But when you're when you're dealing with 13:25 when you're using because pineal on is is interesting. 13:28 It's thought of like the central nervous system, the brain. 13:32 Whereas epithelium is really the pineal gland. 13:35 It's much more specific. 13:37 But pineal on is more of brain and nervous system. Yes. 13:41 Yeah. Absolutely. 13:42 Right, right. 13:43 But now from the standing, 13:49 the functional activity 13:51 of parts isn't very necessary to understand 13:55 the functional activity of organs. 14:01 Affects these parts, right. 14:04 Because all of people's 14:08 have a tissue specific activity. 14:11 People influence the tissue 14:15 they are were isolated from. 14:19 If the retinal amine. 14:22 Yes. In the retinal pipe isolate from the retina. 14:26 That is why these tides affect only the retina. 14:31 Right. 14:32 If the, the sum of isolate from the pine gland. 14:38 That is why these eyes regulate the functional activity of Pine Island. 14:43 But we understand 14:47 the pineal gland is a very, very important hour. 14:51 And the crying and the crying are glad 14:55 because pioneer gland regulates 14:59 not only the level of our melatonin, by the way, melatonin. 15:05 And it is our hormone of aging but high. 15:11 Nagaland regulates a temporary immune system. 15:17 Some of the biological cycles 15:21 read them. 15:22 It is very very important gland. 15:24 Yeah yeah. 15:25 If we use the pineal gland 15:29 Kryptonite, that is why we can regulate our 15:33 all of metabolic processes in our organism. 15:38 And these tides, 15:41 with the time Olympic tide showed them 15:45 as a decrease of mortality rate in 15 years clinical investigation. 15:50 Yeah, that's a. Crazy trial. Yes. 15:52 Clinical instigation amount of the people, it is 15:55 true, is a huge scientific walk. 16:00 And coming soon. 16:02 It is really generous because he discovered it. 16:07 Not only the regulation 16:11 of metabolic processes baptized, but he 16:17 he discovered the 16:19 the regulation of aging process. 16:23 Slow down the the aging process. 16:26 Yeah, yeah, I know that is I have a question for you about epitaph on 16:31 and even maybe epithelial. 16:33 And because one of the functions people talk about or one of the, 16:36 one of the effect is to upregulate to affect the activity of an enzyme 16:42 called telomerase, which helps to protect the telomeres on the end of the DNA. 16:48 Right. To increase. 16:49 Maybe the Hayflick, but there's but there are many people 16:53 who express concern that if it if it if it affects telomerase, 16:59 could it possibly be of benefit to a cancer cell 17:02 that also wants to have long telomeres in the, 17:05 you know, in the research and in the all the work of professor 17:10 over the years and even in your clinical experience. 17:13 Have you seen that there's that the body somehow there's a there's a distinction 17:17 that's made between an oncology cell and a normal cell. 17:20 Or would you avoid using Apatow on with someone if there's a risk of cancer? 17:26 It's a hard question to answer because cancer is so complicated. 17:30 But I'm I'm curious about your thoughts because everybody is running around 17:35 with theories and hypotheses. 17:36 And I think this and I think that and I'm like, 17:39 this is one of the questions I've wanted to ask for so long. 17:42 What are your thoughts on that? 17:44 Yes, you're right. 17:45 It is really a very important part in this. 17:50 In the science it's very important question. 17:53 But what is a very important that all of the pictures 17:58 it doesn't matter epithelium or the lone or pioneer gland 18:03 that these diets regulate 18:07 gene activity and regulate the functional activity of the difference 18:13 organ, not stimulation, not depressed and epithelium. 18:19 Yes, of course by epithelial is a possible 18:24 to prolong the prolonged of the telomeres. 18:28 Yeah. 18:29 Your but not more that it is a necessary right. 18:35 Because people really have a regulate activity regulation activity. 18:41 Yeah it is very very important. 18:43 And on the one hand the other hand, 18:46 we talk about this with you, that 18:50 pineal gland and immune 18:55 and times peptide are carried out 18:58 50 years clinical investigation 19:02 and mortality rate decreased 19:05 because the level the level of cancer genesis 19:10 among of this patient decreased 3 or 4 times. 19:15 Right. 19:16 According to the control group. Yeah. Yeah. 19:19 Why haven't seen different and other big tides. 19:24 Because having some type ties 19:27 have 15 years clinical investigation. 19:31 Yeah. 19:32 There are no any previous with the same clinical investigation. 19:37 It is very very important. Yeah. 19:40 Yeah of course I think you agree with me 19:44 that is it possible to create is possible. 19:47 Create is very 19:50 molecules with very high activity. 19:54 Many, many, many 19:59 molecules with 20:01 maybe more strong that big tides. 20:04 But not all of them have the complicated. 20:09 Some of them have the complications. 20:11 They have very, very highly complex. 20:14 Yeah, yeah. 20:15 But sorry, I was going to ask you, 20:18 in that 15 year trial that professor did with the 20:22 and the people were 65 between the ages of 65 to was it 75. 20:28 I bought? Yes. Around. That 20:31 he took the patients with the 60 years old. 20:34 Yeah, around 60 years old. 20:36 So that's good news for me. 20:38 It's perfect time. 20:39 So did he. 20:40 I'm 56. 20:42 So how long? 20:43 So. But but he and and this is an important point also for. 20:48 So the first point that you just made which I think is can never be repeated 20:51 enough about the bio regulators is that they are they regulate function, 20:56 they modulate function, they normalize, they don't boost.
How Bio Regulators Work at the Gene Level 21:00 So they're not, you know, like the epitaph with the telomeres. 21:03 It's not pushing the telomere length. 21:06 It's just it's just normal. 21:08 It's just bringing it back to homeostasis or trying to bring it to homeostasis. 21:13 But in that 15 year study where and I think 21:16 it's important to mention also that the the peptides that they use 21:20 then were epithelial and they were the natural extracts. 21:24 They were not Italian and they were the much more natural extracts. 21:30 How long did the people in the study group. 21:34 So we had the control 21:35 group were getting 21:37 their vitamin injections because they didn't know what they were getting. 21:40 And then the study group was getting the injections of a petition and timeline. 21:45 Did they get them for 15 years or did they get them for just two years? 21:49 Like, how long did they receive the injections? 21:53 Because I know they were studied for 15 years. 21:55 But how long were they did they give did they get 21:58 the administration of the bio regulators? 22:01 Okay. 22:03 In these clinical 22:05 our patients got a big tides twice a year, 22:11 twice a year or twice a year during, 22:16 each course was for ten days. 22:20 Okay. Ten days. 22:21 Yes. That's amazing that that is that is really amazing. 22:25 So they got basically 40 doses spread out over two years. 22:30 And then the effects last like impacted their health for 15 years. 22:36 But I would like to mention 22:41 that the significant results 22:47 in mortality rate we got only in two years 22:52 after this clinical investigation 22:57 that this fact explain. 23:02 That these people 23:05 have a regulation activity 23:08 not hormones not effect as antibiotics. 23:12 Because all this step by step regularly 23:17 regulation the functional activity 23:20 of cells of the tissue 23:24 and normalize of all metabolic processes. 23:28 Yeah. Yeah. 23:28 No it's it's it's really quite spectacular. 23:31 So how do so most people don't have access right now 23:36 to Epithelium and Timoleon. 23:39 They're hard to they're hard to get outside of Russia. 23:42 I mean maybe in Russia you can get them. 23:43 But when out here we can get maybe 23:46 well we can get the natural extract, the oral natural extracts. 23:51 Right. 23:52 And or we can get things like this product from nano Pep, which is synthetic, 23:58 but they only have very they only have a couple of options. 24:01 They have it on they have this numerics which is the immune, which is Thiemo 24:05 Dean and Dylan, which I shouldn't say just this because this is very powerful, 24:10 but how did these compare to the epithelium 24:15 and the Timoleon like would you would, could you use these only for ten days 24:20 or do you think you need to 24:21 use this, a product like like a net like the synthetics, 24:25 would you need to use it for a longer period to get a similar impact, let's say. 24:31 Or is the ten days enough? 24:33 Sorry, but I would like to start your answer 24:36 for your questions with a very important detail. 24:39 Please do. 24:39 Yes, I think some of the problems appeared 24:45 because there are many names of deputize. 24:49 Oh yeah, laws on 24:52 mean epithelial mean. 24:54 But what is very important 24:58 that the molecules in the different 25:03 different products 25:05 is absolutely the same. 25:08 All is the newest trademark of the name of these. 25:14 Of these for example a. 25:20 Pineal gland. 25:21 Yes, yes. 25:23 Extracted. 25:23 Excellent appetite. 25:26 Yes. Is another one. Yes. Yes. 25:30 It is a complex of pictures from Pine Island. 25:36 Absolutely. 25:36 The same molecules as in our medicine, 25:42 in our drug, in the Russia. 25:45 But but in Russia 25:49 we produce as injectable. 25:52 But in Europe we decided to 25:57 to repeat a little bit, repeat this one. 26:00 We take absolutely the same molecule. 26:04 But we told you about the 26:10 the difficult to 26:12 to receive the permission for injectable 26:18 medicine. 26:19 And that is why convention decided to 26:23 to produce a sublingual. 26:27 Yes before the effect. 26:31 Absolutely the same. 26:33 Of appetite to epithelium. Yes. Yes. 26:36 Not epithelial. It alone is different. Yeah. 26:39 Well injectable medicine in Russia because these extract 26:44 epithelium is synthetic peptide. 26:48 Yes. In extract epithelial. 26:52 They are a python in X. Absolutely. 26:55 But there's more there's more. 26:57 Yes yes yes yes. 26:59 So there's and first of all this is necessary to understand 27:03 that there are extract there. 27:06 There is a acting there is a synthetic surface. 27:10 And it doesn't matter. 27:11 What is the name of this one. 27:13 It was only these trademark. 27:17 Yeah, yeah. 27:17 No I know I have a, I made a table with all the different names 27:21 of each of the peptides so people could start to. 27:24 And also it's important to know what, what each name refers to 27:28 so that you understand how to use it and what it's for because they're going to 27:33 they're going to be a little bit different. 27:34 So I have a question for you. 27:36 If if professor created, you know, developed appetite for the 27:42 for the pineal gland by regulator, why didn't he do the same thing 27:46 for the adrenal by a regulator or the like the other organs? 27:50 Is it because he kind of 27:52 did he feel that it wasn't necessary or he just kind of ran out of time or. 27:56 No, no no no no no. 27:57 We produced in the for brain for Thomas in in 28:03 our Italian company produces this type. 28:08 And you showed me this this this one. Yes. 28:13 But but this company or maybe the only thing that I've seen available. 28:17 And this guys, for those of you who are listening to this, this is Nano pep. 28:21 So Nano pep, we can buy now, which is the thymus and villain and villain. 28:25 This is immune. 28:26 You can buy the appetite or you can buy a Patel on. 28:29 But do they have I've not seen available 28:33 to us other formulas that would address different organ systems. 28:38 Is that because they're just not 28:39 available outside of Russia, or because they're coming? 28:43 Because of their coming? I'm very excited about that. 28:45 But it's only the Italy only is Italy is is produced. 28:49 And of course we cannot produce the injectable. 28:52 But for these we produce as a spray 28:56 because it is very important 28:59 way for it is really a sublingual. 29:03 Delivery serie. Good. 29:05 Because very quickly all of the short people prayed to blood 29:10 and they have absolutely the same effect. 29:14 Not similar. 29:15 Very similar effect is in for sure. 29:18 For sure. 29:19 And I guess what I was asking is there's no there's no liver. 29:23 There's no liver version of this is there. 29:26 Yeah. Oh I haven't seen it. Okay. 29:29 We have for brain, for regional, for nervous system, 29:33 for Levi, for for an exceptional complex for man. 29:37 Special complex for lady. Yes. Absolutely. Right. 29:40 And this is under the Nano Pep brand. Sorry. 29:43 This is the brand nano pep or it's a different company that produces it. 29:47 No, no, no, this. Company, this company. 29:49 Okay, cool. 29:50 All right, let's let's go back to 29:53 to the script here because I have a list. 29:56 We got a little bit of off script, but I want to get back to some of this 30:00 because, you know, my curiosity takes over and not sometimes there might be people 30:04 listening to this who don't, 30:06 who don't know the bio regulators as well as some of the listeners 30:09 who are more familiar. 30:10 So, so when when we talk about how they work 30:14 and I think you mentioned this earlier, I just want to confirm for the audience 30:18 that the way the bio regulator works, that makes it different from almost 30:22 any other peptide out there that people are marketing is 30:25 they're really working as gene expression modulators. Yes. 30:29 This is this is what they're doing.
Telomeres, Cancer Concerns, and Safety 30:31 It's activity at the gene expression level. 30:33 It's not it's not attaching to a receptor outside the cell. 30:37 It's it's this is an epigenetic switch flipper. 30:42 Absolutely. 30:43 Having sown in his scientific investigation, 30:47 having sun prune that 30:50 regulates gene activity. And 30:55 because people 30:57 have a binding size with this gene 31:02 and regulate the gene activity, a protein synthesis begins. 31:08 And that is why it is way for regulation 31:13 of functional activity of tails. 31:16 And that is where tissue and the hostages of the whole organism. 31:20 Perfect, beautiful. 31:22 And so there's also a concept about how they influence cell differentiation. 31:28 Is that basically what you just said through the the genetic the genetic impact 31:33 and then up regulating the production of proteins at a cellular level. 31:37 And this is where we see this whole cell differentiation start to, to happen. 31:41 I mean it's like magic really. It's amazing. 31:44 Yes, yes. 31:47 My work was with 31:52 some of my scientific work was with the non differentiation cells. 31:58 And it really for me 32:02 it was surprised when I first time received 32:06 that under the effect of different guys different tissue appeared. 32:14 We took non special model. 32:17 We took a non differentiation cells. 32:21 The raw materials of a frog. 32:24 And under the effect of the original prepared 32:31 retinal cells nervous cells 32:33 and pigmented maybe appears. Wow. 32:37 And this fact explain why we 32:43 see the positive clinical results 32:47 among of our patients with 32:50 so difficult congenital diseases. 32:53 As a rating it is pigmentosa for example of course, 32:57 and it is very important 33:01 to understanding this fact because 33:06 every organs in our organism 33:08 have have a non differentiation cells, stem cell cells 33:14 and and our reserve of our organism are our 33:21 reserve of capabilities capabilities. 33:25 Is it possible only if we can regulate our non differentiation cells. 33:32 And it's those molecules that 33:37 regulate of these 33:39 these not differentiation cells. 33:42 That's incredible. 33:43 That's I never really thought about it that way. 33:46 But that is really so crazy. 33:50 Okay. 33:50 When you I don't know if you spend any time 33:52 listening to the chatter that's going on in the wellness space, 33:56 but if you do, when they talk about bio regulator peptides, 34:01 what do you think is the most common oversimplification that they make? 34:05 And that's assuming you pay any attention to the wellness world. 34:08 So maybe you don't. 34:10 But do you hear people saying things about bio regulators 34:14 and you just go, oh my God, no, stop, please. 34:17 Of course. I. 34:20 Of course, I think impossible to achieve one. Yes. 34:25 Only this one. Medicine. 34:28 Yes, yes. 34:29 They are not the silver bullet. Yes. 34:31 Even it is a pioneer. 34:33 Glenn dies that created cabin song. 34:39 It is longevity. 34:41 It is a difficult work. 34:44 First of all, it is a 34:48 buried them. 34:49 It is our meals, our physical activity. 34:55 It is 34:58 our examination of our health and 35:03 the scientific proven medicine. 35:05 It is only the last part of our longevity and our health. 35:11 And some of the people 35:14 who want to be the health 35:17 and to achieve the 120 years 35:22 to try to use any, any, 35:27 any medicine, any or 35:32 some of these for, for, for maintains of his work. 35:36 But yeah, sometimes it is not good because sometimes these, 35:42 these medicine of these, 35:46 these. Like interventions. 35:48 Are you talking about like plasma replacement or they're talking about. 35:53 Yeah. Yeah. 35:53 So like things like remixing metformin 35:57 like the more extreme 35:59 fringe stuff like the plasma paresis, all of these things. Yes. 36:03 Not positive for health. 36:06 Yeah. 36:08 Yeah. 36:08 And I think it is very important to 36:11 use only proven medicine 36:16 things or medicines 36:18 or some of the way to support of the house. 36:22 Yeah, yeah. 36:23 No I agree I don't disagree with you. 36:25 I think, you know, it's interesting. 36:26 I think in this space people are so, you know, they're so motivated in some ways. 36:31 I mean we learn from from everybody's experience. 36:34 But there there are people who are very willing to, to do the latest, 36:38 greatest thing very quickly because because of a and because of 36:43 and even if it's a well-developed hypothesis, it's still just a hypothesis. 36:47 We don't have the data to show what's going to happen in ten, 15, 36:52 20, 30, 40 years. 36:54 So I think that's a good, very good point. 36:59 Do you there's one issue that keeps coming up 37:02 in, in even in the scientific space, and that is the 37:07 when it comes to the six year and the 12 years, the 15 year study 37:11 that Kevin Son did with the old people and then the elderly people, he did it. 37:15 He did the second one with the elderly people. 37:17 One issue that people keep bringing up is that nobody was ever. 37:21 And I don't know if anybody even tried, 37:23 but that there is no independent replication of those results. 37:27 What do you think? 37:29 What do you think prevented, like the wider validation of this work 37:32 outside of the group of scientists that Kevin, 37:36 because it wasn't Kevin said all by himself in a lab. 37:38 I mean, he he had teams of scientists working with him. 37:42 What do you think has stood in the way of replicating this work 37:45 so that it would be more broadly appreciated or accepted? 37:50 Because certainly in North America, you get a lot of scientists that go. 37:53 Nobody's ever been able to reproduce that. 37:56 It is only my opinion, but I think 37:58 maybe it is really very difficult to repeat 38:03 this investigation for 15 years. 38:05 It it will take a long time. 38:08 It is true to do much money just to all. 38:11 Fortunately, fortunately, fortunately, and I think now it is necessary to 38:18 to use the results of this huge investigation. 38:23 And for me, sometimes it is not clear why the some of the doctors 38:30 decide to prescribe the new new dosage 38:35 of some of the people's old. 38:40 And why every time 38:42 I ask some such doctors, okay, it is very good. 38:46 But you did check this. 38:49 Your your your methods of these 38:53 your your method of this or this one or not. 38:59 Why you decided it that these your variants 39:02 more better than variance from having. 39:06 So why? 39:07 Yeah, I'm a doctor and I use 39:10 only the scientific proof investigation. 39:14 Right. 39:15 But there is no scientific proof investigation for what they're doing.. 39:19 Is absolutely riptides absolutely safe 39:23 because we carried out 39:26 taxi investigation Chronicle instigation, of course. 39:30 But, it is necessary. 39:33 I think it is may idea each doctor to receive the 39:39 the maximum positive results and why it is necessary prescribe 39:45 your vision for this one 39:48 and not take the results of investigation. 39:51 I cannot understand why. 39:53 Yeah. 39:54 Yeah, well, maybe because they once they feel they start to understand 39:59 how they work, they start to imagine, you know, they start to create different 40:06 because because I guess where it comes from is or maybe where it might come from 40:10 is that Kevin Sun spoke very clearly that the way to use the bio regulators 40:15 most effectively was not one at a time, 40:18 but to combine maybe 2 or 3 together. 40:23 Depending on the on the condition to get the best results right. 40:28 And so we see the blood vessel bio regulator, for example.
Clinical Protocols, Stacking, and Dosing 40:31 We see it show up all the time in these. 40:34 We can call them stacks now because as you explained earlier, with the eye, 40:39 proper circulation health of the blood vessels is I mean, 40:42 it's a foundational need for anything to go well in the body. 40:47 And so and I know I've come across documents 40:50 that really clearly specify which 2 or 3 peptides to use, 40:55 depending on the situation, the condition we're trying to address. 41:01 Do you think that maybe if people decide 41:04 that they're going to use more, add a couple more to it? 41:08 Do you think that will do you think maybe it's a waste, 41:11 or do you think that maybe it could be a problem for the way 41:13 the peptides interact or work together in the body? 41:18 The laws 1000 41:21 scientific publication in scientific journal. 41:24 And it is really we carried out many clinical investigation. 41:30 And of course, you're absolutely right. 41:32 If the patient have the sum of serious disease, 41:37 for example, as debate is 41:40 as it is, why we have to regulation 41:43 not only metabolic process but an immune system, vessels, 41:49 binary gland and 41:53 urological, see if the patient have the summer complication. 41:58 But of course we have a special program with peptides for such patients. 42:05 And we try to teach all of the doctors 42:10 these this this program. 42:14 Yeah. 42:15 And I guess there's probably like for the diabetic person 42:18 we have just taking diabetes as an example. 42:21 Right. 42:21 If we think about all of the different issues that they're dealing with. 42:24 So you you mentioned obviously diabetic neuropathy, 42:27 which is it's kind of almost like an end closer to an end stage of a disease. 42:32 But there's there's kidney challenges early. 42:36 There's we have to talk about the liver. 42:38 We have to talk about the pancreas. 42:40 We have to talk about the blood vessels, the heart, like there's 42:43 very few systems that are going to not be impacted. 42:47 And so I guess the question is in the, in the, in the protocols that you have 42:52 that you teach doctors, I would imagine that it's not so much 42:56 that you can't use them all at once. 42:58 It's that there's an order, maybe there's an order of operations where 43:01 first we must deal with this, 43:03 then we can deal with this and then we can deal with that. 43:06 Is that because otherwise you just end up with a hodgepodge 43:11 of stimulation to the body, asking the body to do repair. 43:15 And it may be. 43:16 Is it possible that if it's in the wrong order, it's 43:18 not going to be dangerous, but it's not going to be as effective? 43:21 Well, first. 43:22 Of all, as a doctor must have to know the disease. 43:27 And according to the problem, this patient, of course, it is necessary 43:32 to prescribe the different different 43:35 bites coding to do the. 43:41 To to the to these disease. 43:44 Yeah. Absolutely. Absolutely. 43:46 Absolutely. Right. Yeah. 43:47 So it's the order of operations that matters. 43:49 And so if people use because I've, you know, I had someone recently 43:54 say to me, oh yeah, I'm going to use five bio regulators at one time. 43:57 And to me that sounds like it's a lot. 44:00 You're asking a lot of the body at one time. 44:05 And maybe it would be better to split it up 44:08 into 2 or 3 and then another two after the fact. 44:11 What are your thoughts on like again, is it a question of safety 44:15 or is it just a question of not of efficacy? 44:19 First of all. 44:20 Of course it is a safety. 44:21 Yeah. First of all, it is a safety. Yeah. 44:24 But of course it depends on what we want to achieve 44:29 or if these patients are necessary to treatment. 44:34 If of course, I can prescribe 44:37 the five big types and medicine if I want to, 44:43 if the patient won't prevent some of disease, of course 44:47 it will be better to to 44:49 get if this patient get only 2 or 3 44:55 this but step by step 44:58 according to the age, according to the biological age. 45:02 Because in for example, in our medical center 45:06 for our patients, we check their biological age, 45:10 we check the level of melatonin, the length of telomeres. 45:15 We do a genetic passport. 45:18 According to the 45:21 patients with different diseases, 45:24 somewhat disease or cancer disease. 45:27 We prescribe the special treatment. 45:30 Of course, it depends on the patient's impossible 45:34 to recommend 45:37 price. 45:38 If I if I can see. That for sure. 45:41 And I guess I guess in this case it was this is 45:44 this is the the crowd that is very focused on longevity and health span. 45:49 So they don't necessarily have health. 45:51 I mean, everybody has something going on. 45:53 It's at a certain age, right? 45:55 You if nothing else, even if you're very healthy, 45:58 you might have a weakness, as you just said, like whether it's 46:01 a genetic predisposition or, you know, metabolically, you're not quite as great 46:05 as you used to be, like whatever the case may be. 46:09 But, but, but the people we're seeing very often who want to throw everything 46:14 at the, at the problem but the kitchen sink and they're in a rush. 46:18 Right. 46:18 So they want to do it all at the same time. 46:20 Is really this, this crowd, this, this growing population of people 46:25 that have become aware that they don't want to get sick as they age, and 46:29 so they want to do everything they can now to prevent that, that decline. 46:34 And I guess what with the five peptides at a time, 46:38 what we're seeing is people who think that, you know, 46:39 if I could just cram it all in, in less time, it will be better for me. 46:43 And I think what you're saying is maybe a little bit of patience 46:47 and going a little bit more slowly might be more beneficial and be more specific. 46:52 Yeah. 46:53 But I would like to draw attention. 46:55 But in the patient hearts, patient has a really serious disease. 47:01 Yes. Of course. 47:03 Are all people only the only. 47:10 We only 47:10 add to the main the therapy of this for for such patients. 47:15 Not it is a main therapy of course. 47:17 Oh yeah. 47:18 It's additive to even like more medications. 47:21 Yeah. 47:21 That was, that was a really great I think the one of the books 47:25 that did a really good job speaking about that is the it's a very tiny little book. 47:30 It's not very complicated. 47:31 It's the the bio regulator peptide revolution 47:35 book by Mario's Doctor Mario's. 47:39 I forget his last name starts with a K, but he he he cites 47:43 a lot of different instances where, for example, 47:45 there was one study where there were patients who had COPD 47:48 and the the control group were the patients 47:52 that only got the medicine, and the test group 47:55 were the patients that got the medicine, plus the bio regulators. 47:58 And so I think what was so interesting in that book is it really makes the point 48:03 that the bio regulators play very well with medicine. 48:07 They add to the medicine, they improve the results. 48:10 Sometimes you can use less medicine as a result, you know, 48:14 like you just see better results. 48:16 But they don't replace the medicine. Yes. 48:18 Because peptides are regular is a metabolic process. 48:23 And that is why is it possible to decrease 48:27 the level of the medicine 48:29 if the patients get I have many patients 48:34 with a different disease, for example hypotonic disease. Yes. 48:37 And under the of the vessels of pineal gland peptides. 48:42 We manage with these problems. 48:44 And my patients 48:47 I get the dosage more smaller than the patients 48:52 with the same level of hypotonic diseases, but without tides. 48:57 It is true. 48:58 And when you say hypertonic, are you talking about high blood pressure? 49:01 Yes. Yeah. Okay. 49:02 Sorry I didn't I didn't fully understand. 49:04 Sorry, sorry, Tony disease is the patients with a high the high pressure. Yes. 49:10 And that. 49:11 In your opinion is there anyone who should not use 49:14 the bio regulators that you've seen so far clinically? 49:18 Is there a population of people you'd be like for those people, 49:21 or is it a situation where with people with significant disease, 49:26 they really shouldn't use them without the guidance of a physician? 49:29 Well, first of all, I think the main problem in 49:34 not problem, but the main yes, of course the problem. 49:39 Cause we haven't medicine respected 49:44 efficient medicine injectable in the European country, first of all. 49:49 And we have all the food supplements with people, of course the molecules. 49:54 Absolutely same. 49:56 And the facts about it, they are not legal 50:02 as a medicine. 50:04 Right. 50:04 Maybe, maybe this remains a question, the main of the problem. 50:09 But if the doctors go to the scientific 50:14 congress and scientific meeting, 50:17 and if such doctors are read, the scientific publications, 50:23 of course, doctors and stand about this part. 50:27 But to tell the truth, unfortunately it doesn't matter where 50:31 in European country, in Russia, in America, America. 50:36 Some of the doctors don't read scientific scientific journals. 50:40 Yeah, that is true. Sorry. That is. 50:43 And with only the according 50:46 to the algorithm and the some of the program. 50:51 So I'll show the government hospital right. 50:55 So so let me ask you about a couple of different populations of people 50:59 that ask me all the time. 51:00 Should I use can I use bio regulators. 51:03 So and I think that in the literature they are used with children 51:07 sometimes but have much lower doses. 51:11 Is that but but again 51:12 for children I would think what now we're getting into therapeutic world. 51:16 We're talking about a child who has who has a problem. 51:19 So now it should be under the guidance of a physician. 51:22 Like we're not we're not doing anti-aging strategies with a child. 51:25 Of course, it depends on the children of. 51:27 Of course, yes. 51:28 But you know, we have, let's say, in North America right now, 51:31 there's an epidemic of children with metabolic, metabolic imbalance. 51:36 In Russia, in the Russian pharmaceutical 51:41 market, there is a medicine 51:46 pipe medicine for brain, 51:49 special for children, special for children. 51:52 Okay. Yes. 51:54 For special for children, for cerebral 51:58 palsy or some. 52:01 These medicines. 52:03 Special for children. Of course. 52:05 We have only the 1 or 1 legal 52:11 medicine respected for children fully this one. 52:15 Just the one for cerebral palsy. 52:17 Yes, yes. This one in the. 52:20 Of course. 52:23 Is it possible to if the patient, 52:25 if the children have problems with the health of course the possible
Children, Pregnancy, and Healthy Aging Use 52:32 to to to give such children these types of course. 52:38 But I cannot recommend as a doctor children 52:44 because clinical investigation among the children we didn't carry out. 52:51 Perfect. Great. 52:52 That's the answer I was looking for. 52:55 I think it's important to say that, and it's important for people to hear that 52:58 from from one of the best informed sources on the planet. 53:01 And then the next population that asks a lot about this is women 53:05 who are pregnant. 53:06 My response is not that different than what you just said, but what. 53:10 This story, but the same. The same answer. 53:13 There's no perfect, beautiful. 53:15 Thank you. Yes, yes. Okay. 53:18 But. Sorry, absolutely the same answer. 53:21 But of course, we carry out the investigation and animals pregnancy. 53:28 Yeah. 53:28 And we did not receive any toxicity, 53:32 any complication, but not 53:36 we didn't carry out among the people. 53:39 Yeah. 53:40 And so and sometimes the animal research doesn't translate directly to humans. 53:43 So we just yet. 53:45 Yeah. Yes. Absolutely. Right. 53:47 Okay. 53:48 So is it possible is it possible for people to do too much to. 53:53 And now I'm talking about in the, you know, in the relatively healthy 53:58 people who are trying not to slow down their aging, right. 54:01 Is it possible for people. 54:02 To do two two high dose, two frequent cycling, 54:07 like is it possible 54:08 or they run their cycles for too long, like for example, 54:11 there's some doctors out there who are saying, oh, I recommend 54:14 people use it on every single day are all year long. 54:18 What do you say to those people? Is it possible? 54:21 Is it possible they're just doing too much? 54:22 Or the hand? Of course 54:26 they will not receive any complication 54:28 and any toxicity action on the 54:33 the big dosage of of peptides, 54:38 because peptides regulate the only the 54:44 gene, only the corresponding part of the gene. 54:49 And that is why he. 54:53 Don't looking for this one. 54:57 This doesn't work. 54:58 But on the on the on the other hand other hand, 55:02 it is really really strange why it is necessary to use every day. 55:08 I asked the same question. 55:10 I thought maybe they they know something I don't know. 55:12 Oh no. 55:13 No, we we haven't results. 55:17 We haven't such investigation. 55:20 First of all, they haven't been studied that way. 55:22 Also, it begs the question why? Right. 55:25 Because if if in the studies, in those studies, the six year 55:29 and the 15 year study, you were able to accomplish so much 55:34 with so little, why do people think they need to continue this indefinitely? 55:39 I, I agree with you. 55:41 I think we'll have to find 55:42 one of these people and ask them why 55:44 they think this is important, but thank you for answering that 55:49 in your opinion, 55:50 for from a longevity perspective, not therapeutic. 55:54 At what age does it make sense to start using bio regulators 55:58 as a healthy aging strategy? 56:00 If somebody just interested in saying, you know, I want to do appropriate, 56:06 let's say, ten day cycles just to help myself age better. 56:12 What age do you think is an age that they might think about doing that? 56:16 Can they answer all these phrases 40 years having? 56:21 Yeah. 56:22 Show that, 56:25 his prepares can slow down aging process. 56:31 Right. 56:32 But it's cannot stop 56:35 aging process in our is yes of. 56:38 100%. Yes. 56:39 And if you want to achieve the longevity. 56:43 Yes of course we are. 56:47 We have to use these people's according to the 56:54 the results of scientific investigation. 56:57 Of course. Yes. 56:59 And of course we have to maintain our health with our very them our. 57:09 Of course, meals, our physical exercises. 57:13 And of course it is 57:17 very important for our health. 57:20 And if we decided to change our, 57:27 our behavior in, in our life, of course it 57:33 it necessary to use only 57:37 the scientific, scientific, scientific medicine 57:41 and scientific scientific 57:45 race for for this one. 57:48 Okay. 57:49 So okay, so so I guess I mean the scientific literature, 57:53 the study that that Kevin Son did was with this 60 year old people. 57:58 But would it be are you saying that maybe at 40 years old 58:01 there's no research and so maybe it's too soon to start? 58:04 Or because you could say that it's easier to slow down 58:08 aging if you start a little bit before you're older. 58:11 Right? So let's say a 40 year old person or, 58:16 you know, 58:16 for a 20 year old person, it would probably be too soon 58:19 because you're you're young, assuming that you're living a healthy lifestyle 58:23 and eating the right, you know, you're doing all the things. 58:26 But do you think it would be too early at a 58:29 for someone in their 30s or their 40s to start? 58:33 Maybe it is necessary. 58:34 First of all, it is necessary to check the biological age. 58:38 Of course. First, yes. 58:40 And if the biological age 58:45 doesn't match to passport age. 58:48 Of course it is necessary to to first of all, to think about your health. 58:54 First words. 58:55 Just the second part. 58:57 Of course, the uses this big time. 58:59 And so if you're. 59:00 But how much younger like look at Bill Lawrence for example. 59:05 His biological age is crazy. 59:07 I don't know, it's like 23 or something. 59:09 Soon he's going to be a baby. 59:11 But he's so he continues, you know, he continues to cycle his bio regulators. 59:16 Whereas for me, I'm according to the last test 59:19 I did, I'm 14 years younger than my than my passport age. 59:23 So does that in your opinion, does that mean okay, you know what, Natalie? 59:27 Just maybe use a couple of cycle once or twice a year, and then you're good 59:32 just to maintain or because I'm older, should I use them a little bit more? 59:38 But let's say someone or someone who's 45, 59:42 whose biological age is 35, 59:45 would you say to that person, just wait, you know, just let it go? 59:49 Or would you say, maybe, oh, 59:51 you can do a little bit of fine tuning, but you don't need much. 59:55 For prevention. 59:56 Of course. Yes, but, 1:00:00 I will 1:00:01 recommend such creation, of course, to do the genetic passport. 1:00:05 Because, because according to the the coding 1:00:10 to the position of several disease, 1:00:13 I can prescribe the different types. 1:00:18 Right. 1:00:18 That's where you're going to put your focus. Right. 1:00:20 So for me, if I have a predisposition to type two diabetes, we're 1:00:24 going to focus on the metabolic piece of the puzzle more than other things.. 1:00:28 Pancreas peptides. 1:00:29 First of all pine angle and device and vessel peptides. 1:00:33 Sorry, but if you ask me about yourself 1:00:37 I have three these pictures. 1:00:40 Yeah. No, that makes that makes perfect sense. 1:00:42 I've done that stack before. I will have to do it again someday. 1:00:45 You talked earlier about the the the retinol diseases, right? 1:00:50 The retinitis pigmentosa. 1:00:51 And I think this is something that's important for the audience 1:00:55 to understand that you use the bio regulator peptides, 1:00:58 but you also used this is a very this is a very complex protocol. 1:01:02 Yes. There's also medications involved. 1:01:05 Can you just explain? 1:01:07 Basically it wasn't just the bio regulators 1:01:09 or was it just the bio regulators that you start 1:01:11 that you see the best results with because you now work with people like this 1:01:15 ongoing in your clinic? 1:01:16 This is a big focus of the clinic. 1:01:18 I think 1:01:18 you're one of the few places on the planet that actually moves the needle here. 1:01:22 Yes, for original diseases picked out by regulators, 1:01:27 it is really a brilliant medicine 1:01:30 because because we can manage 1:01:34 with these serious diseases 1:01:38 as h degeneration 1:01:42 where the dry form retinitis pigmentosa, diabetes 1:01:47 mellitus, this retinopathy and of course 1:01:52 this, these retinal diseases, 1:01:56 only these big tides 1:01:58 we can stop of pathology process
Stem Cells, Misconceptions, and Future Research 1:02:01 because we have many, many patients with this disease. 1:02:05 And first of all, it is very important we can to 1:02:10 to to give such patients the visual acuity. 1:02:14 It is incredibly. Yeah. It's. 1:02:18 Yes. Yeah. 1:02:19 And so it's a combination of things. 1:02:21 It's the bio regulator peptides plus other treatments as well. Yes. 1:02:25 The pathogenesis of retinal disease. 1:02:29 First of all, when we prescribe all of the treatment respected, 1:02:34 first of all we we have to understand the 1:02:38 the battle genetic of any diseases. 1:02:41 And according to participate genetic we prescribe 1:02:46 these medicines. 1:02:49 Yeah 100%. 1:02:51 You mentioned earlier we talked earlier about the non differentiated stem 1:02:55 cells in the organ that respond when you administer the bio regulators. 1:03:01 I know that there's work being done 1:03:04 in an Italian university with someone that you know quite well 1:03:10 looking, 1:03:10 studying stem cells and bio regulators. 1:03:14 Is there any information coming from there yet that you can share 1:03:19 that would indicate that for all these people who are doing stem 1:03:23 cell therapies right now, that there might be a benefit to also 1:03:29 adding the bio regulator to the stem cell therapy? 1:03:33 Yeah. 1:03:34 Yes, it is very, very important question because I, I have mentioned 1:03:41 that ties people's 1:03:45 a boost for, 1:03:48 for the differentiation of the stem cells 1:03:52 and combination of stem cells with guides 1:03:58 can give as a really good results 1:04:01 because peptides are information molecules. 1:04:06 And these molecules 1:04:10 that push of differentiation, cells differentiation 1:04:16 according to the tissue specific of peptides. 1:04:20 Yeah it's perfect okay. 1:04:22 Last few questions before we go. 1:04:24 And what are the for you that you have heard. 1:04:28 There are any myths or misunderstandings about bio regulators that you would like 1:04:34 to just say right now, just stop it, that you would like to clear up right now? 1:04:40 I think, first of all, that some of the people 1:04:46 decided that people that 1:04:50 are Alex are elixir of age. 1:04:55 Yeah, no, people 1:04:59 are substance that regulates 1:05:04 our aging process. 1:05:06 Unfortunately, even pioneer gland prepared 1:05:11 cannot stop of aging process. 1:05:15 And if we want to chief longevity, of course 1:05:20 we have to maintain our health, 1:05:25 our behavior, our buried 1:05:28 and of course use beautiful. 1:05:32 And what area of bio regulated peptide research 1:05:35 are you the most excited about over the next five years? 1:05:40 Yes, I think it is a future when we 1:05:45 when we will know absolutely 100% 1:05:51 how the peoples regulate the genetic 1:05:54 beautiful 1:05:56 which which regulates which gene. 1:05:59 Yeah. Because. 1:06:00 Because they regulate many different genes. Right. 1:06:03 The pineal gland bio regulator regulates where is it? 1:06:06 Hundreds of genes. 1:06:07 Like it's not just one little switch I think is what people imagine, right. 1:06:11 They're like, oh, it's going to be one gene. 1:06:13 It's like, no no. No no no. 1:06:15 Gene. But having sun 1:06:18 research these 1:06:20 the received these results only in vitro. 1:06:23 But it is necessary to repeat in vivo. Yeah. 1:06:27 And do you think that work is happening now or is it going to happen. 1:06:30 It's happening now. Beautiful. 1:06:33 Do you think that so you've made it clear in this interview that the bio regulators 1:06:38 are part of the pharmacy of used medically in Russia? 1:06:44 Do you think it'll ever cross over into other countries like Europe and 1:06:49 and North America, I hope I hope so too. 1:06:53 It is. 1:06:53 Mind me. 1:06:54 It is. It is a dream for sure. 1:06:57 Okay. 1:06:57 You're not going to like this question, but imagine, just in general, 1:07:01 if you were going to build a foundational healthy aging stack today, 1:07:06 what would it what would the peptides be if you were to say, 1:07:10 into the general population, if you were going to do just one stack 1:07:14 once or twice a year, what would it be? Yes. 1:07:18 According to the results of 15 years investigation. 1:07:22 Yep, I think yes. 1:07:25 You want to eat sheave our all 1:07:29 and each people have all the longevity and all we have to 1:07:36 get a pioneer 1:07:38 Glenn and time as to why is a year. 1:07:42 Beautiful? Beautiful. 1:07:44 Last question. 1:07:46 What do you know now about aging, repair and resilience that you wish 1:07:51 every 40 year old person understood 1:07:54 are your final message to the audience? 1:07:58 I think I think we have to think about the positive. 1:08:03 Yeah. Yeah. Yes. 1:08:05 Remain quantitative. 1:08:06 Yeah. Yes. 1:08:07 And believe 1:08:10 that we can manage 1:08:14 to all of the bad situation and achieve our 1:08:20 beautiful. Thank you. 1:08:22 Thank you Doctor Trofimov. 1:08:24 This has been a wonderful conversation. 1:08:26 Thank you so much for making the time for this because I know you're very busy. 1:08:31 You're traveling, you're you're not 1:08:33 you're not sitting around resting on your laurels at all. 1:08:36 So thank you so much for taking the time. 1:08:38 It's been an honor and a pleasure to speak with you today. 1:08:41 Thank you. 1:08:41 Thank you very much. 1:08:42 Thank you very much for our invitation. 1:08:45 It is really I am grateful to be here. 1:08:49 Thank you very much. Thank you. 1:08:51 And I will include in the show notes links to the, the, the 1:08:55 a couple of the studies we talked about today and also 1:09:00 to just a couple of research articles I think would be good. 1:09:04 I'll run them by you first and you'll tell me what you think 1:09:06 just to help people get a foundation. 1:09:08 Thank you again. It's been a pleasure. 1:09:11 Thank you very much. Thank you. Thank you very much.
Comments